J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CASAO, M. A.
Right arrow Articles by GAMAZO, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CASAO, M. A.
Right arrow Articles by GAMAZO, C.
Agricola
Right arrow Articles by CASAO, M. A.
Right arrow Articles by GAMAZO, C.
J. Med. Microbiol. -- Vol. 50 (2001), 965-968
© 2001 Society for General Microbiology
ISSN 0022-2615


HOST RESPONSE TO INFECTION

Promotion of platelet aggregation by sera from brucellosis patients with antiphosphatidylcholine antibodies

M. ÁNGELES CASAO, RAMÓN DÍAZ, ANTONIO ORDUÑA* and CARLOS GAMAZO

Departamento Microbiología. Universidad de Navarra, Clínica Universitaria de Navarra. 31080, Pamplona and *Departamento Microbiología, Hospital Universitario, Facultad de Medicina, Universidad de Valladolid, Spain

Corresponding author: Dr C. Gamazo (e-mail: cgamazo{at}unav.es).

Received 27 Dec. 2000; revised version accepted 4 May 2001.

Abstract

Results obtained in this study suggest that in human brucellosis there is an antibody response against platelet-activating factor (PAF) and phosphatidylcholine (PC). The specificity of the antiphospholipid response was determined by inhibition assays. The PAF molecule was able to inhibit the anti-PC activity of the brucellosis-control serum. This inhibition capacity of PAF was similar to that of the phosphorylcholine (PYC) group. These results suggest that the inhibition activity could be attributed to the PYC group present in both PAF and PC molecules. Consequently, these findings support an immunodominant role of PYC in the antiphospholipid response of brucellosis. Furthermore, sera from patients infected with Brucella organisms were able to cause platelet aggregation, as were brucella phospholipids, suggesting a possible role of the antiphospholipid antibodies and phospholipids in the inflammatory response in brucellosis.




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
F. Apostolou, I. F. Gazi, A. Kostoula, C. C. Tellis, A. D. Tselepis, M. Elisaf, and E. N. Liberopoulos
Persistence of an atherogenic lipid profile after treatment of acute infection with brucella
J. Lipid Res., December 1, 2009; 50(12): 2532 - 2539.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
D. J. Comerci, S. Altabe, D. de Mendoza, and R. A. Ugalde
Brucella abortus Synthesizes Phosphatidylcholine from Choline Provided by the Host.
J. Bacteriol., March 1, 2006; 188(5): 1929 - 1934.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2001 Society for General Microbiology.